Search results for "HLA-DR3"

showing 10 items of 23 documents

HLA-B8,DR3 phenotype and lymphocyte responses to phytohaemagglutinin.

1990

Several reports have shown that HLA-B8,DR3 positive subjects may display some changes in immune parameters when compared with HLA-B8,DR3 negative ones and are prone to develop several immunological diseases. In the present study we have analysed the proliferative response to phytohaemagglutin (PHA) in HLA-typed healthy subjects. A twin method was also employed to assess the role of genetic and environmental factors in the regulation of the response to the mitogen. It was not possible to demonstrate any difference in proliferative response to optimal doses of PHA between groups of subjects carrying or not carrying the HLA-B8,DR3 phenotype. When suboptimal responses were studied, however, the…

AdultMaleLymphocyteImmunologyImmunogeneticsmedicine.disease_causeLymphocyte ActivationHLA-B8 AntigenImmune systemHLA-DR3 AntigenGeneticsmedicineTwins DizygoticHumansPhytohemagglutininsPhytohaemagglutininbiologyCell growthEnvironmental factorTwins MonozygoticPhenotypeProliferative responsemedicine.anatomical_structurePhenotypeImmunologybiology.proteinFemaleJournal of immunogenetics
researchProduct

A genetically determined high setting of TNF-alpha influences immunologic parameters of HLA-B8,DR3 positive subjects: implications for autoimmunity.

2001

The 8.1 ancestral haplotype (AH) is a common Caucasoid haplotype carried by most people who type for HLA-B8,DR3. It seems unique in its association with a wide range of immunopathologic diseases. Healthy subjects bearing this haplotype demonstrate several alterations of immune response. This article will focus on the identification of the mechanism(s) of disease susceptibility of 8.1 AH. In 13 carriers of 8.1 AH, and 43 negative patients, enzyme immune assays serum levels of tumor necrosis factor (TNF)-alpha, soluble endothelial leukocyte adhesion molecule-1 (sELAM-1), cortisol, and interleukin(IL)-10 were determined. In addition, quantification of cytokine produced in vitro after mitogen s…

AdultMalemedicine.medical_specialtyHydrocortisonemedicine.medical_treatmentImmunologyHLA-DR3Biologymedicine.disease_causeAutoimmunityAutoimmune DiseasesHLA-B8 AntigenImmune systemHLA-DR3 AntigenInternal medicinemedicineImmunology and AllergyHumansGenetic Predisposition to DiseaseCells CulturedTumor Necrosis Factor-alphaHaplotypeInterleukinGeneral MedicineMiddle AgedInterleukin-10Interleukin 10EndocrinologyCytokineHaplotypesImmunologyTumor necrosis factor alphaFemaleE-SelectinHuman immunology
researchProduct

In Vitro Cytokine Production by HLA-B8, DR3 Positive Subjects

1994

It is well known that healthy subjects carrying the HLA-B8,DR3 haplotype may show an impairment of immune system, the T cells being the most affected. To gain insight into the mechanism(s) of the impairment displayed by these subjects, efforts have been centered on the study of in vitro cytokine production because of the pivotal role played by these mediators in the activation and control of several immune functions. The available results indicate that the ability to several immune functions. The available results indicate that the ability to produce interleukin-1 (IL-1), IL-2 and the soluble form of its receptor (sIL-2R) is impaired in HLA-B8,DR3 positive healthy subjects. To better charac…

AdultMalemusculoskeletal diseasesInterleukin 2Cellular immunitymedicine.medical_treatmentImmunologyAutoimmunityPeripheral blood mononuclear cellHLA-B8 AntigenInterferon-gammaHLA-DR3 AntigenImmune systemimmune system diseasesmedicineHumansImmunology and AllergyInterferon gammaPhytohemagglutininsInterleukin 6Cells CulturedInterleukin 4biologyInterleukin-6Receptors Interleukin-2Middle AgedRecombinant ProteinsCytokineAntibody FormationImmunologyLeukocytes Mononuclearbiology.proteinCytokinesInterleukin-2FemaleInterleukin-4medicine.drugAutoimmunity
researchProduct

Soluble Interleukin-2 Receptor Secretion Defectin Vitroin HLA-B8, DR3 Positive Subjects

1990

Several studies have shown that HLA-B8,DR3 positive subjects may display T cell dysfunctions. Recently, a soluble form of the receptor for IL-2 (sIL-2R) has been demonstrated in human sera and in vitro-stimulated culture supernatant from human T lymphocytes. In the present paper we report sIL-2R serum levels and sIL-2R production from peripheral blood mononuclear cells in HLA-B8,DR3 positive subjects. We found that HLA-B8,DR3 positive subjects have the highest values of serum sIL-2R, but comparing the values of these subjects with those of negative ones no significant difference was observed. As regards the in vitro production of sIL-2R, no difference exists for unstimulated cultures, where…

AdultMalemusculoskeletal diseasesInterleukin 2medicine.medical_specialtyAdolescentT cellImmunologyStimulationHuman leukocyte antigenBiologyLymphocyte Activationmedicine.disease_causePeripheral blood mononuclear cellAutoimmune DiseasesHLA-B8 AntigenAutoimmunityHLA-DR3 AntigenT-Lymphocyte Subsetsimmune system diseasesInternal medicinemedicineHumansImmunology and AllergyGenetic Predisposition to DiseaseReceptorSicilyCells CulturedImmunologic Deficiency SyndromesReceptors Interleukin-2Middle AgedIn vitroDiabetes Mellitus Type 1medicine.anatomical_structureEndocrinologySolubilityImmunologyLeukocytes MononuclearFemaleDisease SusceptibilityProtein Processing Post-Translationalmedicine.drugAutoimmunity
researchProduct

Complete congenital heart block in autoimmune hepatitis (SLA-positive).

1994

Complete congenital heart block is a serious complication of neonatal lupus erythematosus which most often occurs in children of mothers suffering from connective tissue disease. We report the occurrence of complete congenital heart block associated with autoimmune hepatitis (SLA-positive). A 32-year-old woman was treated for more than 10 years for autoimmune hepatitis (SLA-/ANA-positive) and remained in clinical remission under immunosuppressive therapy. She showed an MHC-haplotype typical for autoimmune hepatitis (A1, B8, DR3). After a normal first pregnancy, an emergency caesarean section was performed in the 32nd week of her second pregnancy because of fetal bradycardia. The child died …

AdultPediatricsmedicine.medical_specialtyHeart diseaseHeart blockAutoimmune hepatitisAutoantigensAutoimmune DiseasesHLA-B8 AntigenHepatitisHLA-DR3 AntigenRNA Small CytoplasmicmedicineHumansNeonatal lupus erythematosusHLA-A1 AntigenAutoimmune diseaseHepatitisPregnancyHepatologybusiness.industrymedicine.diseaseConnective tissue diseaseHeart BlockHaplotypesRibonucleoproteinsImmunologyChronic DiseaseFemalebusinessJournal of hepatology
researchProduct

Morphea after silicone gel breast implantation for cosmetic reasons in an HLA-B8,DR3-positive woman

1997

We describe an HLA-B8, DR3-positive patient with localized morphea after silicone gel breast implantation for cosmetic reasons. We believe that this case suggests that a genetic background, i.e. HLA-B8, DR3 haplotype, is involved in the autoimmune response to silicone.

Adultmusculoskeletal diseasesmedicine.medical_specialtyBreast implantationBreast ImplantsMammaplastyImmunologyMammary glandCD4-CD8 RatioSiliconesHLA-B8 AntigenScleroderma Localizedchemistry.chemical_compoundHLA-DR3 AntigenSiliconeLocalized morpheamedicineHumansImmunology and AllergySurgery Plasticskin and connective tissue diseasesGlucocorticoidsbusiness.industrytechnology industry and agricultureGeneral Medicinemedicine.diseaseConnective tissue diseaseSurgeryPlastic surgerymedicine.anatomical_structurechemistryImmunologyPrednisoneFemalebusinessMorpheaCircumscribed scleroderma
researchProduct

Budesonide induces remission more effectively than prednisone in a controlled trial of patients with autoimmune hepatitis.

2010

Autoimmune hepatitis (AIH) is a chronic liver disease associated with cirrhosis and liver failure. Corticosteroid therapy induces long-term remission but has many side effects. We compared the effects of budesonide (a steroid that is rapidly metabolized, with low systemic exposure) and prednisone, both in combination with azathioprine.We performed a 6-month, prospective, double-blind, randomized, active-controlled, multicenter, phase IIb trial of patients with AIH without evidence of cirrhosis who were given budesonide (3 mg, three times daily or twice daily) or prednisone (40 mg/d, tapered to 10 mg/d); patients also received azathioprine (1-2 mg/kg/d). Treatment was followed by a 6-month, …

BudesonideAdultMalemedicine.medical_specialtyCirrhosisAdolescentAzathioprineAutoimmune hepatitisChronic liver diseaseGastroenterology03 medical and health sciences0302 clinical medicineHLA-DR3 AntigenDouble-Blind MethodPrednisoneInternal medicineMedicineHumansProspective StudiesBudesonideChildAgedHepatitisIntention-to-treat analysisHepatologybusiness.industryGastroenterologyMiddle Agedmedicine.disease3. Good healthHepatitis AutoimmuneEndocrinology030220 oncology & carcinogenesisPrednisone030211 gastroenterology & hepatologyFemalebusinessmedicine.drugGastroenterology
researchProduct

Defective expression of CD95 (FAS/APO-1) molecule suggests apoptosis impairment of T and B cells in HLA-B8, DR3-positive individuals.

1997

Activation-induced apoptosis is one of the primary control mechanisms for the negative selection of an immune response, leading to maintenance of immune homeostasis and selective T cell deletion. The interaction between the surface molecule Fas and its ligand (FasL) has been proposed as a primary mechanism initiating T cell apoptosis. The T cell receptor modulates the expression and function of these molecules. Defects in the Fas/FasL apoptosis pathway have been shown to result in autoimmune disease in humans and in murine models. Because subjects carrying the HLA-B8, DR3 haplotype show a number of immune dysfunctions, including membrano-proliferative glomerulonephritis, systemic lupus eryt…

CD3 ComplexT cellCD8 AntigensT-LymphocytesImmunologyAntigens CD19Lipopolysaccharide ReceptorsApoptosisBiologyFas ligandHLA-B8 AntigenImmune systemHLA-DR3 AntigenmedicineImmunology and AllergyCytotoxic T cellHumansfas ReceptorAutoimmune diseaseB-LymphocytesHistocompatibility TestingT-cell receptorGeneral Medicinemedicine.diseaseFas receptorFlow Cytometrymedicine.anatomical_structureApoptosisImmunologyCD4 AntigensCancer researchHuman immunology
researchProduct

B8, DR3 antigens and production of human leucocyte migration inhibitory factor (LIF) by mononuclear cells stimulated with concanavalin A (Con A)

2008

LIF release by Con A stimulated mononuclear cells was evaluated in 67 randomly selected healthy Sicilians typed for HLA antigens. The results show that B8 and/or DR3 positive subjects release less LIF than negative ones, suggesting that this immunological response might be controlled by HLA-linked immune response (Ir) gene(s).

Leukocyte Migration-Inhibitory FactorsImmunologyHuman leukocyte antigenInhibitory postsynaptic potentialBiochemistryPeripheral blood mononuclear cellMonocytesHLA-B8 AntigenHLA-DR3 AntigenImmune systemAntigenHLA AntigensConcanavalin AGeneticsHumansImmunology and AllergyGeneLymphokinesbiologyChemistryHistocompatibility Antigens Class IIGeneral MedicineMolecular biologyConcanavalin AImmunologybiology.proteinLeucocyte migrationTissue Antigens
researchProduct

HLA, aging, and longevity: a critical reappraisal.

2000

Despite a large number of studies, available data do not allow at present to reach definitive and clear conclusions on role of HLA on longevity, owing to major methodological problems, such as serological and molecular typing of different loci, insufficient sample sizes, different inclusion criteria and age cut-off, inappropriate mixing of data referred to people from 58 to over 100 years of age, inappropriate control matching, and neglected consideration of sex-related effects and the different genetic make-up of studied populations. However, within this confused scenario, some data emerge. First, two studies that do not fit the biases above discussed show that some HLA alleles are associa…

MaleAgingmedia_common.quotation_subjectImmunologyLongevityHuman leukocyte antigenMajor histocompatibility complexEvolution of ageingHLA-B8 AntigenHLA-DR3 AntigenPleiotropyHLA AntigensImmunology and AllergyHumansAllelemedia_commonAgedGeneticsAged 80 and overbiologyHaplotypeHomozygoteLongevityGeneral MedicineImmunosenescenceHaplotypesbiology.proteinFemaleHuman immunology
researchProduct